MRVI Maravai LifeSciences Holdings, Inc.
Stable Earnings Power
F 30.0 / 100 pillar composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.

Grade overrides the 30.0 pillar composite — hard gates always win.

Profitability

Weight: 20%
B 70
  • 5yr Avg ROIC 87.6%
  • Operating Margin Trend -30.20 pp/yr

Capital Efficiency

Weight: 15%
F 11
  • 5yr Avg ROE 0.7%
  • 5yr Share-Count CAGR 4.4%

Growth Quality

Weight: 15%
D- 31
  • 5yr Revenue CAGR -30.6%
  • 5yr EPS CAGR 7.1%
  • Revenue-Growth Years (5) 2/5

Cash Generation

Weight: 15%
A- 80
  • 5yr FCF Margin 15.5%
  • 5yr FCF/NI Conversion 2.15x

Balance Sheet

Weight: 20%
F 10
  • Net Debt / EBITDA 10.00x
  • Interest Coverage (EBIT/Int) -7.71x
  • Altman Z-Score 2.02

Stability

Weight: 15%
C 53
  • EPS Volatility (σ/μ) 0.23
  • Piotroski F-Score 4
  • Negative-Revenue Years (5) 3/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

1 of 1 gurus held; 1 added.

Holders
1
Avg Δ position
+12.6%
New buys
0
Full exits
0
  • Wood increased +13%
As of Q1 2026